口腔鳞状细胞癌患者第二原发癌风险
基于芬兰癌症登记1953-2015年6602例初诊口腔鳞状细胞癌患者,计算第二原发癌的标准化发病比和超额绝对风险。提示临床应关注第二原发癌风险并对患者进行宣教。
要点
- 口腔鳞癌患者第二原发癌发生率为10%(640/6602)。
- 第二原发癌风险显著高于一般人群,SIR为1.85。
- 每1000人年超额绝对风险为8.78例。
核心结论
- 口腔鳞状细胞癌患者治疗后第二原发癌风险显著高于一般人群,临床应警惕并对患者进行宣教。
研究设计与样本
- 回顾性队列研究,从芬兰癌症登记处检索1953-2015年初诊口腔鳞状细胞癌患者,共6602例。
主要发现
- 6602例初诊口腔鳞癌患者中发生640例(10%)第二原发癌。
- 第二原发癌的超额绝对风险(EAR)为8.78(95%CI 7.29-10.26)/1000人年。
临床怎么用
- 口腔鳞癌患者治疗后应意识到第二原发癌风险,并进行患者宣教和长期随访规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence and survival of oral squamous cell carcinoma (OSCC) patients have increased in recent years. Understanding their long-term survival aspects is essential for optimal treatment and follow-up planning. Almost one in five cancers diagnosed occurs nowadays in individuals with a previous diagnosis of cancer. METHODS: Patients diagnosed with primary OSCC during 1953-2015 were retrieved from the Finnish Cancer Registry. Both standardized incidence ratios (SIR) and excess absolute risk (EAR) per 1000 person-years at risk (PYR) of second primary cancer (SPC) were calculated relative to the general population. RESULTS: Among 6602 first primary OSCC patients there were 640 (10%) SPCs. The SIR for SPCs was 1.85 (95% CI: 1.71-1.99, P < .001) corresponding to an EAR of 8.78 (95% CI: 7.29-10.26). CONCLUSIONS: Health care professionals should be aware of the second primary cancer risk after management of primary OSCC and patients need to be counseled about this phenomenon.
引用
- Mroueh R, Nevala A, Haapaniemi A, et al. Risk of second primary cancer in oral squamous cell carcinoma. Head Neck. 2020. PMID: 32057158. doi:10.1002/hed.26107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。